Health Care/Hospital

Medical Informatics Corp. Commended by Frost & Sullivan for Setting a New Standard of Care through its SaaS-based Solution, Sickbay™

Sickbay's™ technology allows hospitals to enable rapid data collection from diverse medical devices ensuring clinical staff have access to near real-time bedside data to support remote monitoring and patient centered analytics at scale SANTA CLARA, Calif., June 1, 2021 /PRNewswire/ -- Based on i...

2021-06-01 20:00 1319

BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study

VANCOUVER, BC and LYON, France, June 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (US OTCQB: BVAXF)("BioVaxys" or "the Company") is pleased to announce that its bioproduction partner Bio Elpida of Lyon, France, has initiated construction of a new Good Manufacturing Prac...

2021-06-01 20:00 3718

Occlutech takes important step towards approval in China

SCHAFFHAUSEN, Switzerland, June 1, 2021 /PRNewswire/ -- Occlutech AG ("Occlutech" or the "Company") today announces that the planned recruitment of 180 patients has been reached in the Company's trial inChina for its ASD Occluder. The Occlutech ASD Occluder is used in the treatment of Atrial Sept...

2021-06-01 19:02 1638

Scripps Research Institute testing shows Viraleze highly active against UK COVID strain

MELBOURNE, Australia, June 1, 2021 /PRNewswire/ -- Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product...

2021-06-01 17:30 1356

Australia's original prolonged-release melatonin now available over the counter at pharmacies

MAIN POINTS * Circadin® prolonged-release melatonin is now available without prescription1 * Circadin® is clinically proven in people aged 55 and over2 to help them fall asleep quicker, sleep better, wake refreshed, and in turn improve quality of life3 * Circadin® mimics the effect of the b...

2021-06-01 17:05 1103

Genoox accelerates genomic data community platform expansion with $8M round and appointment of new Board Chair

PALO ALTO, Calif., June 1, 2021 /PRNewswire/ -- Genoox, the world's first community-driven genomic data platform, announced today that it has raised $8 million in a round led by IN Venture, a Sumitomo Corporation backed venture fund, with participation from Infinity Medical and existing investors ...

2021-06-01 17:00 1110

L Catterton Leads $40 Million Series B Round in Zenyum

HONG KONG, June 1, 2021 /PRNewswire/ -- L Catterton, the largest global consumer-focused private equity firm, today announced that it has invested$25 million in Zenyum, one of Asia's fastest growing direct-to-consumer dental products brands. Existing Zenyum investors, including Sequoia Capital In...

2021-06-01 16:51 1728

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis

Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells Associated with Atopic Dermatitis and Several Other Inflammatory Diseases Moderate-to-Severe Atopic Dermatitis Affects Nearly 30 Mill...

2021-06-01 16:00 4866

100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand

CHRISTCHURCH, New Zealand, June 1, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that St George's Hospital inChristchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction. Today, the innovative radiation therapy device is found in 14 count...

2021-06-01 15:07 4328

AXA becomes the first insurer to offer VHIS product on HKTVmall

HONG KONG, June 1, 2021 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") today announced the new partnership with HKTVmall, the 24-hour online shopping mall operated by Hong Kong Television Network Company Limited ("HKTV") to offer AXA WiseGuard Medical Insurance Plan ("AXA WiseGuard") on its plat...

2021-06-01 15:03 2317

Intellicare partners with UnionBank to open fully digital ePaycard accounts for affiliated doctors

SINGAPORE, June 1, 2021 /PRNewswire/ -- Asalus Corporation (operating under the trade name "Intellicare"), one of the country's leading health maintenance organization (HMO), recently partnered with Union Bank ofthe Philippines (UnionBank), renowned as the "best digital bank" in the country, for ...

2021-06-01 14:19 2374

AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services

SINGAPORE, June 1, 2021 /PRNewswire/ -- AVATAMED (www.avatamed.com ), a precision medicine service company based in Singapore, announced the setting up of a joint lab with Singapore's Institute of Molecular and Cell Biology (IMCB) at the Agency for Science, Technology an...

2021-06-01 09:00 1514

Singapore-based Impact Investor Heritas Capital Announces US$60M First Close of Heritas Growth Fund III to Back Asian Emerging Champions Driving Sustainable Covid-19 Recovery

* Pan-Asia Impact Fund to back high-growth emerging champions developing smart platforms that enhance access to affordable quality healthcare and education for sustainable post-Covid recovery, in line with UN Sustainable Development Goals (SDGs) * Builds on successful track record of earlier ...

2021-06-01 09:00 1961

Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China

SAN FRANCISCO and SUZHOU, China, June 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-06-01 08:00 3823

PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture

TOKYO, May 31, 2021 /PRNewswire/ -- PENTAX Medical (a division of HOYA Group) and Jiangsu Vedkang Medical Science and Technology Co., Ltd (Vedkang) today announced the establishment of a joint venture- PENTAX Medical Therapeutics ( Jiangsu) Co., Ltd.(*) to develop single-use therapeutics products ...

2021-05-31 21:00 2051

PolyU develops biomimetic nanosheet for cancer therapy and imaging

HONG KONG, May 31, 2021 /PRNewswire/ -- A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour development ...

2021-05-31 19:42 2218

RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021

STOCKHOLM, May 31, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021. Also, all new US clinics hav...

2021-05-31 19:33 1572

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery

SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, devel...

2021-05-31 18:33 1322

Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions

SHENZHEN, China, May 31, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women's Healthcare, and Cardiology ultrasound solutions onMay 28, 2021. Underpinned by the theme "In...

2021-05-31 10:15 6650

Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

* HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development * HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021 HOUSTON andSINGAPORE, May 31, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing pr...

2021-05-31 10:00 1681
1 ... 323324325326327328329 ... 552